We would like to cordially invite you to the 14th Annual Meeting of the International Thymic Malignancy Interest Group (ITMIG 2024) which will take place in Yokohama, Japan, October 30th to November 1st, 2024.

We are pleased to announce that the ITMIG annual meeting will partner with the Japanese Lung Cancer Society (JCLS) meeting!

ITMIG is a multidisciplinary society focused on the science, clinical care, research, and advancement of treatments for thymic malignancies. JLCS has a long history of leading the world in multidisciplinary collaboration for the advancement of research and clinical care of lung cancer. ITMIG is proud and honored to partner with the JCLS in these concurrent meetings, which offer a unique opportunity for our organizations and participants to share knowledge, learn from each other, and build lasting bonds.

The integrated meeting is ideal for our mutual interest in scientific advancement and cutting-edge patient care and discovery, thus our motto for the ITMIG2024 conference is:

Together Advancing Discovery, Treatment, and Care

We invite thoracic surgeons, medical oncologists, radiation oncologists, pathologists, radiologists, neurologists, immunologists, nurses, patients, and trainees of all specialties to join us for two days of engagement, and exchange of knowledge on the newest developments in the immunology, neurology and pathology associated with thymic tumors as well as on the latest surgical, neurological, and oncological treatments for these tumors.

In the Scientific Program on October 30 and 31, we will have sessions on multidisciplinary care of patients, state of the art lectures, discussion forums on challenging clinical scenarios, research topics at the forefront of each specialty, junior investigator sessions, patient-centered sessions, oral and poster abstract sessions, specialty workshops and more. Accepted abstracts will be published in the journal Mediastinum!

On the morning of November 1st, 2024, we will hold a special workshop dedicated to the neurologic implications of the thymus and thymic disease, while developing working groups to advance our knowledge and improve care for our patients. This workshop will be open to all and fully multidisciplinary.

Finally, in the afternoon of November 1st, 2024, we will hold committee meetings to which any participants who are interested in increasing their involvement with ITMIG activities are cordially invited.

You will find a preliminary program on the ITMIG2024 conference website. Check back for regular updates and refinements of the program!